Published in Epidemiol Infect on March 12, 2010
World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010. PLoS Med (2015) 1.86
Risk factors for campylobacteriosis of chicken, ruminant, and environmental origin: a combined case-control and source attribution analysis. PLoS One (2012) 1.18
The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseases. PLoS One (2013) 1.17
Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health (2014) 1.17
Methodological Framework for World Health Organization Estimates of the Global Burden of Foodborne Disease. PLoS One (2015) 1.00
Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One (2014) 0.87
Sequelae of foodborne illness caused by 5 pathogens, Australia, circa 2010. Emerg Infect Dis (2014) 0.86
Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathog (2011) 0.84
Economic effects of introducing alternative Salmonella control strategies in Sweden. PLoS One (2014) 0.83
Wild griffon vultures (Gyps fulvus) as a source of Salmonella and Campylobacter in Eastern Spain. PLoS One (2014) 0.78
Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas. Gastroenterol Hepatol (N Y) (2013) 0.77
Antimicrobial resistance and antimicrobial use associated with laboratory-confirmed cases of Campylobacter infection in two health units in Ontario. Can J Infect Dis Med Microbiol (2013) 0.77
Free-living turtles are a reservoir for Salmonella but not for Campylobacter. PLoS One (2013) 0.76
An experience with the Patient-Reported Outcomes Measurement Information System: pros and cons and unanswered questions. Nurs Outlook (2014) 0.75
Chicken Immune Response after In Ovo Immunization with Chimeric TLR5 Activating Flagellin of Campylobacter jejuni. PLoS One (2016) 0.75
Salmonella Serogroup C: Current Status of Vaccines and Why They Are Needed. Clin Vaccine Immunol (2016) 0.75
A method for the enumeration of male-specific bacteriophages in sewage. J Appl Bacteriol (1984) 2.93
Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34
[Acute dysphasia: often there is a readily treatable cause]. Ned Tijdschr Geneeskd (2003) 2.03
Estimating the global burden of foodborne diseases--a collaborative effort. Euro Surveill (2009) 2.01
Ampicillin-dextrin agar medium for the enumeration of Aeromonas species in water by membrane filtration. J Appl Bacteriol (1987) 1.89
Bacteriophages and indicator bacteria in human and animal faeces. J Appl Bacteriol (1986) 1.89
Systematic review: temporary stent placement for benign rupture or anastomotic leak of the oesophagus. Aliment Pharmacol Ther (2011) 1.85
Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer (2008) 1.69
Admission time is associated with outcome of upper gastrointestinal bleeding: results of a multicentre prospective cohort study. Aliment Pharmacol Ther (2012) 1.63
Lack of colonization of 1 day old chicks by viable, non-culturable Campylobacter jejuni. J Appl Bacteriol (1992) 1.58
Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg (1999) 1.56
Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia. Aliment Pharmacol Ther (2012) 1.53
[Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study]. Ned Tijdschr Geneeskd (2005) 1.48
Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology (2007) 1.47
Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. Am J Gastroenterol (1999) 1.45
Prediction scores in gastrointestinal bleeding: a systematic review and quantitative appraisal. Endoscopy (2012) 1.45
The Beta Poisson dose-response model is not a single-hit model. Risk Anal (2000) 1.44
Evaluation of reporting based on descriptional knowledge. J Am Med Inform Assoc (1996) 1.42
False-negative oxidase reaction as a result of medium acidification. Antonie Van Leeuwenhoek (1980) 1.41
The occurrence of Mycobacterium kansasii in tapwater. Tubercle (1980) 1.40
[Diagnosis and treatment of esophageal cancer in the Netherlands: wide variation in the second line]. Ned Tijdschr Geneeskd (2003) 1.40
Factors influencing the miss rate of polyps in a back-to-back colonoscopy study. Endoscopy (2012) 1.39
[Gastrojejunostomy versus endoscopic stent placement as palliative treatment of malignant stenosis of the duodenum: overview of advantages and disadvantages on the basis of a literature study]. Ned Tijdschr Geneeskd (2007) 1.38
5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut (2004) 1.37
Factors affecting the enumeration of coliphages in sewage and sewage-polluted waters. Antonie Van Leeuwenhoek (1983) 1.36
Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol (2011) 1.36
Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer (2003) 1.22
Campylobacter in primary animal production and control strategies to reduce the burden of human campylobacteriosis. Rev Sci Tech (2006) 1.19
Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther (2006) 1.18
The burden of infectious diseases in Europe: a pilot study. Euro Surveill (2007) 1.18
Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage. Aliment Pharmacol Ther (2007) 1.17
Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years. Scand J Gastroenterol (2004) 1.17
Stent-in-stent technique for removal of embedded esophageal self-expanding metal stents. Am J Gastroenterol (2010) 1.16
Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study. Br J Cancer (2006) 1.14
5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B (1998) 1.14
The burden of upper gastrointestinal endoscopy in patients with Barrett's esophagus. Endoscopy (2006) 1.13
Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management. J Thorac Cardiovasc Surg (1996) 1.13
The homeodomain protein CDX2 is an early marker of Barrett's oesophagus. J Clin Pathol (2004) 1.12
Risk of gastroenteritis among triathletes in relation to faecal pollution of fresh waters. Int J Epidemiol (1998) 1.12
Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol (2007) 1.10
Risk of otitis externa after swimming in recreational fresh water lakes containing Pseudomonas aeruginosa. BMJ (1995) 1.08
Sedimentation of free and attached Cryptosporidium oocysts and Giardia cysts in water. Appl Environ Microbiol (1998) 1.08
Risk factors for the presence of Campylobacter spp. in Dutch broiler flocks. Prev Vet Med (2004) 1.06
Safety and efficacy of a new non-foreshortening nitinol stent in malignant gastric outlet obstruction (DUONITI study): a prospective, multicenter study. Endoscopy (2011) 1.05
Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2012) 1.05
Reproducibility of esophageal high-resolution manometry. Neurogastroenterol Motil (2011) 1.04
Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer (1998) 1.03
Normal values for esophageal high-resolution manometry. Neurogastroenterol Motil (2013) 1.02
Otitis externa by Pseudomonas aeruginosa associated with whirlpools. J Hyg (Lond) (1983) 1.02
Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiol Infect (2010) 1.01
Prevalence of meticillin-resistant Staphylococcus aureus amongst professional meat handlers in the Netherlands, March-July 2008. Euro Surveill (2010) 1.01
Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis. Br J Cancer (2007) 1.00
Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans. Ann Oncol (2012) 1.00
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer. Br J Cancer (2002) 0.99
Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy (2004) 0.99
An oligonucleotide hybridization assay for the identification and enumeration of F-specific RNA phages in surface water. J Appl Bacteriol (1996) 0.99
Endoscopic ultrasound-guided ethanol ablation of a symptomatic sporadic insulinoma. Endoscopy (2011) 0.99
Complexing of copper in drinking water samples to enhance recovery of Aeromonas and other bacteria. J Appl Bacteriol (1989) 0.99
Mycobacteria in semi-public swimming-pools and whirlpools. Zentralbl Bakteriol Mikrobiol Hyg B (1985) 0.98
A pro-inflammatory genotype predisposes to Barrett's esophagus. Carcinogenesis (2008) 0.98
Community incidence of pathogen-specific gastroenteritis: reconstructing the surveillance pyramid for seven pathogens in seven European Union member states. Epidemiol Infect (2012) 0.98
Single and sequential biodegradable stent placement for refractory benign esophageal strictures: a prospective follow-up study. Endoscopy (2012) 0.98
Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer (2009) 0.96
Increased risk for Campylobacter jejuni and C. coli infection of pet origin in dog owners and evidence for genetic association between strains causing infection in humans and their pets. Epidemiol Infect (2013) 0.96
Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer (2012) 0.95
Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2009) 0.95
Expandable stents for malignant esophageal disease. Gastrointest Endosc Clin N Am (2011) 0.94
Cost comparison of gastrojejunostomy versus duodenal stent placement for malignant gastric outlet obstruction. J Gastroenterol (2009) 0.94
Oesophagitis is common in patients with achalasia after pneumatic dilatation. Aliment Pharmacol Ther (2006) 0.94
Model studies on a membrane filtration method for the enumeration of coagulase-positive staphylococci in swimming-pool water using rabbit plasma-bovine fibrinogen agar. Can J Microbiol (1985) 0.93
How often is large smaller than small? Lancet (1995) 0.92
The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands. Br J Cancer (2006) 0.92
First data on the Evolution duodenal stent for palliation of malignant gastric outlet obstruction (DUOLUTION study): a prospective multicenter study. Endoscopy (2013) 0.91
Sensation of stasis is poorly correlated with impaired esophageal bolus transport. Neurogastroenterol Motil (2013) 0.91
The contents of free-text endoscopy reports: an inventory and evaluation by peers. Endoscopy (1994) 0.90
Relationship between esophageal contraction patterns and clearance of swallowed liquid and solid boluses in healthy controls and patients with dysphagia. Neurogastroenterol Motil (2012) 0.90
Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989-2003. Br J Cancer (2007) 0.90
Esophageal perforation due to removal of partially covered self-expanding metal stents placed for a benign perforation or leak. Endoscopy (2010) 0.89
Congenital toxoplasmosis and DALYs in the Netherlands. Mem Inst Oswaldo Cruz (2009) 0.89
Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts. Aliment Pharmacol Ther (2008) 0.89
Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus. Anticancer Drugs (2001) 0.89
High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas. Cytogenet Genome Res (2007) 0.89
Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer. Br J Cancer (1999) 0.88
Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria. Hum Genet (1992) 0.88
Surgical treatment of adenocarcinomas of the gastro-esophageal junction. Ann Surg Oncol (2014) 0.87
MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio. J Clin Pathol (2004) 0.87
Predicting presence of intestinal metaplasia and dysplasia in columnar-lined esophagus: a multivariate analysis. Endoscopy (2007) 0.87
Overview of the clinical problem: facts and current issues of mucinous cystic neoplasms of the pancreas. Dig Liver Dis (2008) 0.87
Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin. Surg Gynecol Obstet (1993) 0.87
Experiences and expectations of patients after oesophageal cancer surgery: an explorative study. Eur J Cancer Care (Engl) (2006) 0.86
Comparative study of membrane filtration and enrichment media for the isolation and enumeration of Pseudomonas aeruginosa from sewage, surface water, and swimming pools. Can J Microbiol (1985) 0.86
Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells? Aliment Pharmacol Ther (2006) 0.86
Association between socioeconomic status, surgical treatment and mortality in patients with colorectal cancer. Br J Surg (2014) 0.86
The burden of infectious intestinal disease (IID) in the community: a survey of self-reported IID in The Netherlands. Epidemiol Infect (2011) 0.85
Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer. Eur J Cancer (2002) 0.85
Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction. Cochrane Database Syst Rev (2006) 0.85
C-390 as sole selective agent for isolation of Pseudomonas aeruginosa from hospital waste water. Can J Microbiol (1986) 0.85
Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in a Dutch cohort. Aliment Pharmacol Ther (2007) 0.85
Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands. Aliment Pharmacol Ther (2008) 0.85
Expression of p53 as predictor for the development of esophageal cancer in achalasia patients. Dis Esophagus (2010) 0.85